Research

External collaborations

University of York, Prof. D. Smith. Oct 2001 -

Oswaldo Cruz Institute, Rio de Janeiro, Dr. A. Da-Cruz. 1 Aug 2004 -

St. Mary's Hospital London, Dr. Tiong Ghee Teoh. 1 Jan 2005 -

University of Extremadura, Dr. Jose Fuentes. 15 Aug 2003 -

University of Heidelberg Institute of Immunology, Dr. Markus Munder. 20 Jun 2003 -

CSIC Univeridad de Salamanca Instituto de Biologica Molecular y Celular del Cancer, Dr. Faustino Mollinedo. 15 Feb 2003 -

London School of Hygiene and Tropical Medicine, Dr. Q. Bickle. 15 Nov 2000 -

Max-Planck-Institut für Immunbiologie, Dr M Modolell. 15 Aug 2001 -

Max-Planck-Institut für Immunbiologie, Freiburg, Germany, Prof M Freudenberg and Prof C Galanos. 15 Jun 1992 -

Parc Cientific de Barcelona, Josep Samitier 1-5, Barcelona, Spain, Prof A Celada. 20 Jun 2003 -

Guest lectures

Leishmania major infections in the presence or absence of interleukin-4. North Carolina State University Department of Microbiology, Pathology and Parasitology, Raleigh, NC, uSA. 27 Apr 2001.

High arginase activity during the course of nonhealing L. major infection: an advantage for the host or the parasite?. Residencia Universitaria de Jarandilla de la Vera, Workshop on the role of arginase in the immune sysem, Jarandillia de la Vera. 21 Jun 2003.

Experimental leishmaniasis: a model for polarised T helper 2 responses. Medical Research Club, London. 9 Nov 2001.

Lessons learned from experimental leishmaniasis. 12 International Congress of Immunology, Montreal. 22 Jul 2004.

L-arginine metabolism in macrophages: is it reflecting the immune status?. World Health Organisation, Joint Consultation Meeting on live Leishmania vaccines, Geneva. 4 Jun 2005.

Toll-like receptor activation contributes to the efficient host defence against infection with Leishmania major. British Society for Parasitology, Nottingham, UK. 4 Apr 2005.

Investigation of innate and adaptive immune responses to Leishmania major. Imperial Collge London, Faculty of Medicine; Hammersmith Campus, Infectious Disease Seminars, London. 3 Nov 2005.

Investigation of innate and adaptive immune responses to Leishmania major. London School of Hygiene and Tropcial Medicine, London. 23 Feb 2005.

Experimental leishmaniasis: a model to understand and redirect immune responses resulting in protection or pathology. ornell University, School of Veterinary Medicine,, Ithaca, NY, USA. 24 Jan 2002.

Experimental leishmaniasis: a model to understandand redirect immune responses resulting in protection or pathology. University of Edinburgh, Metchnikoff Club, Edinburgh. 9 Mar 2002.

Experimental leishmaniasis: a model to understandand redirect immune resposes resulting in protection or pathology. University of London, St. George's Hospital, Medical School, London. 11 Jul 2001.

Characterisation and alteration of nonhealing Leishmania major infections in the presence or absence of interleukin-4. University of Manchester, School of Biological Sciences, Manchester. UK. 9 Mar 2001.

Th1/Th2 effector cells: the only determinants for the understanding of leishmaniasis. University of London, Kings College. 30 Oct 2003.